PET-CT Scanner Device Market by Type (Stationary Scanners and Portable/Mobile Scanner), Service Provider (Hospitals, Diagnostic Centers, and Research Institutes), Slice Count (Low Slice Scanner (<64 Slices), Medium Slice Scanner (64 Slices), and High Slice Scanner (>64 Slices)), and Isotope/Detector Type (Flurodeoxyglucose (FDG), 62Cu ATSM, 18 F Sodium Fluoride, FMISO, Gallium, Thallium, and Others) Application (Oncology, Neurology, Cardiology, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030
Breast Imaging Market: Information by Technology (Ionizing and Non-Ionizing Technology), by End User (Hospitals & Clinics and Specialty Centers), and by Region (North America, Europe, Asia-Pacific, and Rest of the World)Forecast till 2027
Breast Imaging Market—Forecast till 2027
Breast imaging Market Forecast
The breast imaging market is exceeded cross USD 6,810.80 million by 2027 to register a healthy CAGR of 8.38%. Breast imaging is a sub-strength of analytic radiology that includes ima…
Epilepsy Devices market to surpass USD 1115.3 million by 2030 from USD 587.4 million in 2020 at a CAGR of 6.62% in the coming years, i.e., 2021-30.
Product Overview
Epilepsy is a chronic neurological condition that produces repeated unprovoked seizures, …
The global lymphoma treatment market grew at a CAGR of around 8% during 2015-2020. Lymphoma refers to a type of cancer characterized by the rapid development of abnormal malignant cells in the lymphatic system. It usually targets the white blood cells (WB…
The global cervical cancer diagnostics market grew at a CAGR of around 7% during 2015-2020. Cervical cancer diagnostics rely on a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells or strains of the human papillomavirus (…
The global osteoporosis drugs market grew at a CAGR of around 5% during 2015-2020. Osteoporosis is a disease that causes deterioration of bone tissues and strength. It is diagnosed by performing different scans, such as X-ray, computed tomography (CT) and…
The global endocrine testing market reached a value of US$ 10 Billion in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 8.7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and eval…